首页> 外文OA文献 >Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359)

【2h】

Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359)

机译：Re：Wells等人：AfliBercept，Bevacizumab或Ranibizumab用于糖尿病黄斑水肿：对比有效性随机临床试验的两年结果（2016年眼科; 123：1351-1359）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mahesh P. Shanmugam; Kaustubh B. Harshey; Rajesh Ramanjulu; Divyansh K. Mishra;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359) [J] . Shanmugam Mahesh P., Harshey Kaustubh B., Ramanjulu Rajesh, Ophthalmology . 2017,第1期

机译：Re：Wells等人：Aflibercept，Bevacizumab或Ranibizumab用于糖尿病黄斑水肿：两年的比较疗效随机临床试验（2016年眼科; 123：1351-1359）
2. Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359) REPLY [J] . Wells John A., Glassman Adam R., Ayala Allison R., Ophthalmology . 2017,第1期

机译：Re：Wells等人：AfliBercept，Bevacizumab或Ranibizumab用于糖尿病黄斑水肿：对比疗效随机临床试验的两年结果（2016年眼科; 123：1351-1359）回复
3. Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: two year results from a comparative effectiveness randomized clinical trial (Ophthalmology. 2016;123:1351-1359) [J] . Venkatesh Pradeep Ophthalmology . 2017,第4期

机译：Re：Wells等人：AfliBercept，Bevacizumab或Ranibizumab用于糖尿病黄斑水肿：两年的比较有效性随机临床试验（眼科。2016; 123：1351-1359）
4. COMPARISON OF CLINICAL EFFECTIVENESS OF LASER ACUPUNCTURE AND AMITRYTALINE IN DIABETIC PERIPHERAL NEUROPATHY (DPN) A SHAM CONTROLED RANDOMIZED CLINICAL TRIAL [C] . Imran Hassan Khan, Shahzad Anwar, Asif Hanif, Mechanisms for low-light therapy IX . 2014

机译：激光控制与阿米替林在糖尿病周围神经病变（DPN）控制的随机临床试验中的临床疗效比较
5. Aflibercept Bevacizumab or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial [O] . John A. Wells, Adam R. Glassman, Allison R. Ayala, -1

机译：AfliberceptBevacizumab或Ranibizumab治疗糖尿病性黄斑水肿：两年疗效比较随机临床试验结果
6. Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study) [O] . A.M.E. Schauwvlieghe, G. Dijkman, J.M. Hooymans, 2015

机译：比较贝伐单抗和雷珠单抗在糖尿病性黄斑水肿患者中的有效性和费用：一项随机临床试验（BRDME研究）

Re: Wells et al.: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1359)

著录项

引文网络

相似文献

相关主题

期刊订阅